Alternatives to EviCure

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

Develops a platform for adaptive clinical trial design and closed-loop execution.

AI-driven platform for protein-level disease mapping and drug discovery.

AI-powered blood test for early cancer detection and subtyping.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Compressing biology to develop the next generation of therapies.

Biotechnology company developing potentially curative cell therapies for cancer patients.

Pioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

AI platform for discovering complex multi-omics signatures for personalized medicine.

Genocure AI is developing AI-powered solutions for oncology drug discovery and development.

Cloud-based platform for reproducible computational research in life sciences.

Biopharmaceutical company developing human haploid stem cells for regenerative medicine and disease therapy.

Omec.ai is a life sciences startup focused on accelerating drug discovery and development through AI.

Developing a novel small molecule inhibitor for ovarian cancer treatment targeting DIO3.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

Biomica is developing a novel microbiome-based platform for the treatment of cancer.

Clinical-stage oncology company developing small molecule therapeutics for rare tumors and aggressive cancers.

Develops and launches Padeliporfin VTP therapy for solid tumor treatment.

Drug discovery and development company using a novel technological approach.

Develops a novel method to predict patient response to immune checkpoint inhibitors in oncology.

Unleashing the power of genomics at scale for biological advances and human health.

Develops and commercializes a novel cancer treatment technology called Alpha DaRT.

Arrakis Bio is developing novel therapeutics for cancer and other diseases using a proprietary gene editing platform.

AI-driven digital twin of embryo development for cell-based therapies.

Genomic and data science company developing novel drugs based on natural resistance mechanisms.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Develops Array Cytometry technology for large-scale dynamic single-cell response acquisition and predictive modeling.

Biopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases.

Developing novel therapeutics for rare genetic diseases.

Leveraging AI and novel technology to extract deep health insights from routine blood tests.

Developing topical treatments to prevent and treat skin toxicities from cancer therapies.

Developing a novel therapeutic approach for neurological disorders using advanced neuroimaging and AI.

Biopharmaceutical startup developing novel therapies for rare genetic diseases.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Computational platform using LLMs trained on biological and chemical data for drug discovery.

Develops bacteria-based immunotherapy to enhance anti-tumor immunity for cancer treatment.

Biotechnology company developing novel therapies for multiple myeloma.

Computational biology platform for optimizing IVF success rates and reducing treatment burdens.

Omnix Medical is developing a novel platform for advanced wound care management.

AI-powered epiproteomic analysis platform for mass spectrometry data.

Develops a platform for individual drug customization using aptamers for cancer treatment.

Galimedix Therapeutics is a clinical-stage biopharmaceutical company developing novel radiopharmaceuticals for PET imaging.

Biopharmaceutical company developing innovative punctal plug technology for eye disease therapies.

AI-powered insights platform for life sciences and biotech workflows.

Revolutionizing drug design using quantum computing, AI, and personalized medicine.

Biotech company developing next-generation immunotherapy agents to unlock the immune system.

Developing novel therapeutics targeting the tumor microenvironment for cancer treatment.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Develops a computational model of the human body for drug discovery and development.

Synthetic biology startup optimizing gene expression for food and biotech applications.

R&D cloud platform for life sciences, enabling scientific innovation and productivity.

A global oncology company developing and commercializing innovative cancer treatments.

Leveraging proteomics and machine learning for improved immunotherapy decisions and drug discovery.

Biotech developing novel technologies to restore physiological balance in apoptosis-related diseases.

AI-powered spatial biology platform for precision medicine and drug development.

AI-driven drug discovery platform accelerating breakthrough scientific research.